News
Patients with psoriasis generally prefer the standard of care over teledermatology, but certain attributes change patient preferences.
A new King’s College London study links abdominal fat—not general obesity—to increased psoriasis risk, especially in women, ...
Among 25 different measures of adiposity, abdominal fat was significantly associated with a risk for psoriasis. Among 25 ...
Symptoms, lesion locations, and morphology are among the features clinicians may use to distinguish hand eczema from hand psoriasis in patients.
The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...
NOW the sun is out, your SPF should be too. Did you know we are recommended to use two shot glasses worth of suncream to cover our body? It might seem excessive, but no patch should be left ...
Pyzchiva® is a key biosimilar value driver for the Sandoz growth strategy. It has been launched in 23 markets in Europe. The autoinjector is now available in Spain and will continue to roll out across ...
Roivant has its own TYK2/JAK1 inhibitor in development in the form of brepocitinib, which the biopharma licensed from Pfizer ...
Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of ...
Sunshine may hold healing rays for a variety of autoimmune diseases such as multiple sclerosis. Scientists are turning this ...
Kathy Reagan Young steps out of the shower in her Virginia Beach home, towels off, dons a pair of protective goggles and ...
Roflumilast foam, 0.3%, proved to be a simplified treatment regimen with high efficacy for patients with scalp and body ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results